FSAG
BIIB icon

Financial Solutions Advisory Group’s Biogen BIIB Stock Holding History

Financial Solutions Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
1,368
-4
-0.3% -$765 0.03% 159
2026
Q1 		$252K Buy
+1,372
New +$253K 0.03% 158

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

Financial Solutions Advisory Group's BIIB Position: Q2 2026 in Review

Financial Solutions Advisory Group reduced its Biogen (BIIB) stake by 0.29% in Q2 2026, selling an estimated $765 and leaving 1,368 shares worth $272K. The position accounts for 0.03% of the portfolio, ranked #159.

Financial Solutions Advisory Group first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Financial Solutions Advisory Group held 1,368 shares of Biogen worth $272K as of Q2 2026.
  • Financial Solutions Advisory Group sold 4 Biogen shares in Q2 2026, an estimated $765.
  • Biogen made up 0.03% of Financial Solutions Advisory Group's portfolio in Q2 2026, its #159 holding.
  • Financial Solutions Advisory Group first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Financial Solutions Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.